Clozapine and Granulocyte Colony-Stimulating Factor
Authors:
- Karen A. MathewsonKMKaren A. Mathewson
- J.-P. LindenmayerJLJ.-P. Lindenmayer
- 1 December 2007
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 27 (6) , 714-715
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The Effect of Sudden Clozapine Discontinuation on Management of Schizophrenic PatientsThe Journal of Clinical Psychiatry, 2006
- Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic TreatmentAmerican Journal of Psychiatry, 2006
- Rechallenge with clozapine following leucopenia or neutropenia during previous therapyThe British Journal of Psychiatry, 2006
- Continuing clozapine treatment despite neutropeniaEuropean Journal of Clinical Pharmacology, 2004
- An alternative to interruption of treatment in recurrent clozapine-induced severe neutropeniaThe British Journal of Psychiatry, 2001
- Structural Evaluation of the Prefrontal Cortex in SchizophreniaAmerican Journal of Psychiatry, 1998
- Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF)The British Journal of Psychiatry, 1998
- Non-malignant neutropeniaBlood Reviews, 1996
- Treatment of Clozapine- and Molindone-Induced Agranulocytosis with Granulocyte Colony-Stimulating FactorAnnals of Pharmacotherapy, 1993
- Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United StatesNew England Journal of Medicine, 1993